Instil Bio (TIL)
(Delayed Data from NSDQ)
$11.88 USD
+0.08 (0.68%)
Updated May 14, 2024 04:00 PM ET
After-Market: $11.84 -0.04 (-0.34%) 7:58 PM ET
2-Buy of 5 2
F Value A Growth C Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
TIL 11.88 +0.08(0.68%)
Will TIL be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for TIL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TIL
What Makes Instil Bio (TIL) a New Buy Stock
Instil (TIL) Stock Rises More Than 20% in a Week: Here's Why
TIL: What are Zacks experts saying now?
Zacks Private Portfolio Services
After Plunging -18.52% in 4 Weeks, Here's Why the Trend Might Reverse for Instil Bio, Inc. (TIL)
Down 61.6% in 4 Weeks, Here's Why You Should You Buy the Dip in Instil Bio, Inc. (TIL)
Down 59.5% in 4 Weeks, Here's Why You Should You Buy the Dip in Instil Bio, Inc. (TIL)
Other News for TIL
Instil Bio price target lowered by $22 at Baird, here's why
Analysts Offer Insights on Healthcare Companies: ANI Pharmaceuticals (ANIP), Fate Therapeutics (FATE) and Instil Bio (TIL)
TIL Stock Earnings: Instil Bio Misses EPS for Q1 2024
Instil Bio reports Q1 results
Instil Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update